Lixiana Acute Stroke Evaluation Registry
NCT03494530
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Ischemic Stroke
Atrial Fibrillation
Hemorrhagic Transformation Stroke
Interventions
DRUG:
Edoxaban 60 MG
DRUG:
Edoxaban 30 mg
Sponsor
University of Alberta